Get started
Gilead Sciences, Inc. 4.6% 01-SEP-2035Gilead Sciences, Inc. 4.6% 01-SEP-2035Gilead Sciences, Inc. 4.6% 01-SEP-2035

Gilead Sciences, Inc. 4.6% 01-SEP-2035

OverviewAnalysisNews

Chart


Full chart

Key terms


Outstanding amount
‪1.00 B‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
4.60% (Fixed)
Coupon frequency
Semi-annual
Maturity date
Sep 1, 2035
Term to maturity
9 years

About Gilead Sciences, Inc. 4.6% 01-SEP-2035


Issuer
Gilead Sciences, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
gilead.com
Issue date
Sep 14, 2015
Identifiers
3
ISIN US375558BG78
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

See how Gilead Sciences, Inc. is moving with its highest-yielding bonds.

Analysis


Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

News